Creatine protects against the convulsive behavior and lactate production elicited by the intrastriatal injection of methylmalonate

Neuroscience

Volumn 118, Issue 4, 2003, Pages 1079-1090

  Royes, L F F ^a   Fighera, M R ^a   Furian, A F ^a   Schneider Oliveira, M ^a   Martins Da Silva, L G ^a   Malfatti, C R M ^a   Schneider, P H ^a   Braga, A L ^a   Wajner, M ^b   Mello, C F ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Convulsion; L methylmalonic acid; Lactate; MK 801; Phosphocreatine; Succinate dehydrogenase

Indexed keywords

CREATINE; CREATINE PHOSPHATE; DIZOCILPINE; LACTIC ACID; METHYLMALONIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SUCCINIC ACID;

ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN LEVEL; CONVULSION; MALE; METABOLISM; NONHUMAN; PRIORITY JOURNAL; RAT; STRIATE CORTEX;

EID: 12444315618     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00978-8     Document Type: Article

References (55)

1. Ames I.I.I.A. CNS energy metabolism as related to function. Brain Res Rev. 34:2000;42-68.
2. Atlante A., Calissano P., Bobba A., Giannattasio S., Marra E., Passarella S. Glutamate neurotoxicity, oxidative stress and mitochondria. FEBS Lett. 497:2001;1-5.
3. Balestrino M. Pathophysiology of anoxic depolarization new findings and a working hypothesis . J Neurosci Methods. 59:1995;99-103.
4. Balestrino M., Rebaudo R., Lunardi G. Exogenous creatine delays anoxic depolarization and protects from hypoxic damage dose-effect relationship . Brain Res. 816:1999;124-130.
5. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principles of protein-dye binding. Anal Biochem. 72:1977;248-254.
6. Brismar J., Ozand P.T. CT and MR of the brain in the diagnosis of organic acidemias experiences from 107 patients . Brain Dev. 16:1994;104-124.
7. Brusque A.M., Rosa B.R., Schuck P.F., Dalcin K.B., Ribeiro C.A.J., Silva C.G., Wannmacher C.M.D., Dutra-Filho C.S., Wyse A.T.S., Briones P., Wajner M. Inhibition of the mitochondrial respiratory chain complex activities in rat cerebral cortex by methylmalonic acid. Neurochem Int. 40:2002;593-601.
8. Brusque A.M., Rotta L.N., Tavares R.G., Emanuelli T., Schwarzbold C.V., Dutra-Filho C.S., Wyse A.T.S., Wannmacher C.M.D., Souza D.O.G., Wajner M. Effects of methylmalonic and propionic acids on glutamate uptake by synaptosomes and synaptic vesicles and on glutamate release by synaptosomes from cerebral cortex of rats. Brain Res. 920:2001;194-201.
9. Brustovetsky N., Brustovetsky T., Dubinsky J.M. On the mechanisms of neuroprotection by creatine and phosphocreatine. J Neurochem. 26:2001;425-434.
10. Cavalheiro E.A., Leite J.P., Bortolotto Z.A., Turski W.A., Ikonomidou C., Turski L. Long-term effects of pilocarpine in rats structural damage of brain triggers kindling and spontaneous recurrent seizures . Epilepsy Res. 32:1991;778-782.
11. de Mello C.F., Begnini J., Jiménez-Bernal R.E., Rubin M.A., De Bastiani J., Da Costa E.J.R., Wajner M. Intrastriatal methylmalonic acid administration induces rotations behavior and convulsions through glutamatergic mechanisms. Brain Res. 721:1996;120-125.
12. 3H]glutamate binding, adenylate cyclase activity and lipid synthesis in rat cerebral cortex. Biochem Mol Biol Int. 42:1997;1143-1150.
13. Dutra J.C., Dutra-Filho C., Cardoso S.E.C., Wannmacher C.M.D., Sarkis J.J.F., Wajner M. Inhibition of succinate dehydrogenase and beta-hydroxybutyrate dehydrogenase activities by methylmalonate in brain and liver of developing rats. J Inherit Metab Dis. 16:1993;147-153.
14. Ferrante R.J., Andreassen O.A., Jenkins B.G., Dedeoglu A., Kummerle S., Kubilus J.K., Kaddurah-Daouk R., Hersch S.M., Beal M.F. Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease. J Neurosci. 20:2000;4389-4397.
15. Fighera M.R., Queiroz C.M., Stracke M.P., Nin Brauer M.C., González-Rodríguez L.L., Frussa-Filho R., Wajner M., de Mello C.F. Ascorbic acid and α-tocopherol attenuate methylmalonic acid-induced convulsion. Neuroreport. 10:1999;2039-2043.
16. Fighera MR, Bonini JS, Oliveira TG, Frussa-Filho R, Rocha JBT, Dutra-Filho CS, Rubin MA, Mello CF (2003) GM1 Ganglioside attenuates convulsions and Thiobarbituric acid reactive substances production induced by the intrastriatal injection of methylmalonic acid. Int J Biochem Cell Biol 35:465-473.
17. Fontella F.U., Pulrolnik V., Gassen E., Wannamacher C.M.D., Klein A.B., Wajner M., Dutra-Filho C.S. Propionic and L-methylmalonic acids induce oxidative stress in brain of young rats. Neuroreport. 11:2000;541-544.
18. Fornai F., Bassi L., Gesi M., Giorgi F.S., Guerrini R., Bonaccorsi I., Alessandri M.G. Similar increases extracellular lactic acid in the limbic system during epileptic and/or olfactory stimulation. Neuroscience. 3:2000;447-458.
19. Holtzman D., Meyers R., Khait I., Jensen F. Brain creatine kinase reaction rates and reactant concentrations during seizures in developing rats. Epilepsy Res. 27:1997;7-11.
20. Holtzman D., Togliatti A., Khait I., Jensen F. Creatine increases survival and suppresses seizures in the hypoxia immature rat. Pediatr Res. 44:1998;410-414.
21. Harrower J.R., Brown H. Blood lactic acid a micromethod adapted to field collection microliter samples . J Appl Physiol. 32:1972;709-711.
22. Hemmer W., Walliman T. Functional aspects of creatine kinase in brain. Dev Neurosci. 15:1993;249-260.
23. Karatzaferi C., De Haan A., Offringa C., Sargeant A.J. Improved high-performance liquid chromatographic assay for the determination of "high-energy" phosphates in mammalian skeletal muscle application to a single-fibre study in man . J Chromatogr B Biomed Sci Appl. 730:1999;183-191.
24. Klivenyi P., Ferrante R.J., Matthews R.T., Bogdanov M.B., Klein A.M., Andreassen O.E., Mueller G., Wermer M., Kaddurah-Daouk R., Beal M.F. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat Med. 5:1999;347-350.
25. Kölker S., Ahlemeyer B., Krieglstein J., Hoffmann G.F. Methylmalonic acid induced excitotoxic neuronal damage in vitro. J Inherit Metab Dis. 23:2000;355-358.
26. Lee W.T., Shen Y.Z., Chang C. Neuroprotective effect of lamotrigine and MK-801 on rat brain lesions induced by 3-nitropropionic acid evaluation by magnetic resonance imaging and in vivo proton magnetic resonance spectroscopy . Neuroscience. 1:2000;89-95.
27. Lipton P., Wittingham T.S. Reduced ATP concentration as a basis for synaptic transmission failure during hypoxia in the in vitro guinea-pig hippocampus. J Physiol (Lond). 325:1982;51-65.
28. Luecke T., Das A.M., Ullrich K. Glutaric aciduria. I 3-hydroxy-glutarate-induced creatinephosphate reduction in mixed cortex cultures can be prevented by creatine supplementation . Ann Neurol. 48:2000;536-537.
29. Luhmann H.J., Heinemann U. Hypoxia-induced function alterations in adult rat neocortex. J Neurophysiol. 67:1992;798-811.
30. Malcon C., Kaddurah-Daouk R., Beal M.F. Neuroprotective effects of creatine administration against NMDA and malonate toxicity. Brain Res. 860:2000;190-198.
31. Marcaida G., Miñana M.D., Grisolía S., Felipo V. Lack of correlation between glutamate-induced depletion of ATP and neuronal death in primary cultures of cerebellum. Brain Res. 695:1995;146-150.
32. Massieu L., Rio D.P., Montiel T. Neurotoxicity of glutamate uptake inhibition in vivo correlation with succinate dehydrogenase activity and prevention by energy substrate . Neuroscience. 106:2001;669-677.
33. Matthews R.T., Andreassen O.E., Yang L., Jenkins B.G., Ferrante R.J., Rosen R.B., Kaddurah-Daouk R., Beal M.F. Neuroprotective effects of creatine and cyclocreatine in animal of Huntington's disease. J Neurosci. 18:1998;156-163.
34. Matthews R.T., Ferrante R.J., Klivenyi P., Yang L., Klein A.M., Mueller G., Daouk K.R., Beal M.F. Creatine and cyclocreatine attenuate MPTP neurotoxicity. Exp Neurol. 157:1999;142-149.
35. McLaughlin B.A., Nelson D., Silver A., Erecinska M., Chesselet M.F. Methylmalonate toxicity in primary neuronal cultures. Neuroscience. 86:1998;279-290.
36. Michaels R.L., Rothman S.M. Glutamate neurotoxicity in vitro antagonist pharmacology and intracellular calcium concentrations . J Neurosci. 10:1990;283-292.
37. Nicholls D.G., Ward M.W. Mitochondrial membrane potential and neuronal glutamate excitotoxicity mortality and millivolts . Trends Neurosci. 23:2000;166-174.
38. O'Gorman E., Beutner G., Dolder M., Koretsky A.P., Bridiczka D., Wallimann T. The role of creatine kinase in inhibition of mitochondrial permeability transition. FEBS Lett. 414:1997;253-257.
39. Okun J.G., Hörster F., Farkas L., Feyh P., Hinz A., Sauer S., Hoffmann G.F., Unsicker K., Mayatepek E., Kölker S. Neurodegeneration in methylmalonic aciduria involves inhibition of complex II and the tricarboxylic acid cycle, and synergistically acting excitotoxicity. J Biol Chem. 277:2002;14674-14680.
40. Roodhooft A.M., Baumgartner E.R., Martin J.J., Bolm W., Van Acker K.J. Symmetrical necrosis of the basal ganglia in methylmalonic acidemia. Eur J Pediatr. 149:1990;582-584.
41. Sauter A., Rudin M. Determination of creatine kinase kinetic parameters in rat brain by NMR magnetization transfer correlation with brain function . J Biol Chem. 268:1993;13166-13171.
42. +-ATPase activity in Madin-Darby canine kidney epithelial cells. Am J Physiol Renal Fluid Electrolyte Physiol. 264:1993;F1021-F1026.
43. Shear D.A., Haik K.L., Dunbar G.L. Creatine reduces 3-nitropropionic acid-induced cognitive and motor abnormalities in rats. Neuroreport. 11:2000;1833-1837.
44. Schinder A.E., Olson E.C., Spuzer N.C., Montal M. Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. J Neurosci. 16:1996;6125-6133.
45. Schurr A., Miller J.J., Payne S., Rigor B.M. An increase in lactate output by brain tissue serves to meet the energy needs of glutamate-activated neuron. J Neurosci. 19:1999;34-39.
46. Schurr A., Payne R.S., Tseng M.T., Gozal G., Gozal D. Excitotoxic preconditioning elicited by both glutamate and hypoxia and abolish by lactate transport inhibition in rat hippocampal slices. Neurosci Lett. 307:2001;151-154.
47. Soltoff S.P., Mandel L.J. Active ion transport in the renal proximal tubule II. Ionic dependence of the Na pump . J Gen Physiol. 84:1984;623-642.
48. Sullivan P.G., Geiger J.D., Mattson M.P., Scheff S.W. Dietary supplement creatine protects against traumatic brain injury. Ann Neurol. 48:2000;723-729.
49. 1H nuclear magnetic resonance spectroscopy and biochemical characterization . Neuroscience. 79:1997;819-829.
50. Toyoshima S., Watanabe F., Saido H., Miyatake K., Nakano Y. Methylmalonic acid inhibits respiration in rat liver mitochondria. J Nutr. 125:1995;2846-2850.
51. Wajner M., Dutra J.C., Cardoso S.E., Wannmacher C.M.D., Motta E.R. Effect of methylmalonate on in vitro lactate release and carbon dioxide production by brain of suckling rats. J Inherit Metab Dis. 15:1992;92-96.
52. Wick M., Fujimori H., Michaelis T., Frahm J. Brain water diffusion in normal and creatine-supplemented rats during transient global ischemia. Magn Reson Med. 42:1999;798-802.
53. Wilken B., Ramirez J.M., Probst I., Richter D.W., Hanefeld F. Creatine protects the central respiratory network of mammals under anoxic conditions. Pediatr Res. 43:1998;8-14.
54. Wyss M., Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol Rev. 80:2000;1107-1213.
55. 2+ block at the N-methyl-D-aspartate receptor underlies receptor during inhibition of neuronal metabolism. J Neurochem. 59:1992;1211-1220.